1. Home
  2. KURA vs FLNC Comparison

KURA vs FLNC Comparison

Compare KURA & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • FLNC
  • Stock Information
  • Founded
  • KURA 2014
  • FLNC 2018
  • Country
  • KURA United States
  • FLNC United States
  • Employees
  • KURA N/A
  • FLNC N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • FLNC Industrial Machinery/Components
  • Sector
  • KURA Health Care
  • FLNC Miscellaneous
  • Exchange
  • KURA Nasdaq
  • FLNC Nasdaq
  • Market Cap
  • KURA 492.9M
  • FLNC 533.2M
  • IPO Year
  • KURA N/A
  • FLNC 2021
  • Fundamental
  • Price
  • KURA $5.61
  • FLNC $4.82
  • Analyst Decision
  • KURA Strong Buy
  • FLNC Buy
  • Analyst Count
  • KURA 12
  • FLNC 18
  • Target Price
  • KURA $24.50
  • FLNC $9.14
  • AVG Volume (30 Days)
  • KURA 1.2M
  • FLNC 5.7M
  • Earning Date
  • KURA 05-01-2025
  • FLNC 05-07-2025
  • Dividend Yield
  • KURA N/A
  • FLNC N/A
  • EPS Growth
  • KURA N/A
  • FLNC N/A
  • EPS
  • KURA N/A
  • FLNC N/A
  • Revenue
  • KURA $67,991,000.00
  • FLNC $2,329,871,000.00
  • Revenue This Year
  • KURA $171.90
  • FLNC $10.80
  • Revenue Next Year
  • KURA $60.51
  • FLNC $22.27
  • P/E Ratio
  • KURA N/A
  • FLNC N/A
  • Revenue Growth
  • KURA N/A
  • FLNC 6.08
  • 52 Week Low
  • KURA $5.41
  • FLNC $3.46
  • 52 Week High
  • KURA $23.48
  • FLNC $26.12
  • Technical
  • Relative Strength Index (RSI)
  • KURA 42.00
  • FLNC 48.22
  • Support Level
  • KURA $5.60
  • FLNC $4.60
  • Resistance Level
  • KURA $6.51
  • FLNC $5.13
  • Average True Range (ATR)
  • KURA 0.37
  • FLNC 0.50
  • MACD
  • KURA -0.00
  • FLNC -0.01
  • Stochastic Oscillator
  • KURA 22.33
  • FLNC 32.76

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About FLNC Fluence Energy Inc.

Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: